Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : XEN-D0501
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Biomapas
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 29, 2022
Lead Product(s) : XEN-D0501
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Biomapas
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : XEN-D0501
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 11, 2017
Lead Product(s) : XEN-D0501
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable